vimarsana.com
Home
Live Updates
SK Life Science Publishes Updated Real-World Experience on C
SK Life Science Publishes Updated Real-World Experience on C
SK Life Science Publishes Updated Real-World Experience on Cenobamate in Epilepsia Based on Recent 100,000 Patient Exposure Milestone
/PRNewswire/ -- SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous...
Related Keywords
Switzerland ,
Canada ,
China ,
Israel ,
United Kingdom ,
Australia ,
United States ,
America ,
Dexcel Pharma ,
Angelini Pharma ,
Louis Ferrari ,
Williame Rosenfeld ,
Marc Kamin ,
Sk Life Science Inc ,
European Union ,
Sk Biopharmaceuticals Co Ltd ,
Sk Life Science Lab ,
Drug Administration ,
Sk Inc ,
Sk Group ,
Endo International ,
Source Sk Life Science Inc ,
Epilepsy Foundation ,
Paladin Labs Inc ,
Ferrari ,
Vice President ,
Medical Affairs ,
Greater China ,
Latin America ,
Middle East ,
North Africa ,
Ono Pharmaceutical ,
Ignis Therapeutics ,
Familial Short ,
North American Antiepileptic Drug ,
Science Labs ,
Science Lab ,